|
Volumn 4, Issue 5, 2002, Pages 441-
|
T-cell therapy targeting minor histocompatibility Ags for the treatment of leukemia and renal-cell carcinoma
a,b a,b a,b a,b a,b c d a,b a,b a,b |
Author keywords
[No Author keywords available]
|
Indexed keywords
CD8 ANTIGEN;
INTERLEUKIN 2;
MINOR HISTOCOMPATIBILITY ANTIGEN;
ADOPTIVE IMMUNOTHERAPY;
CANCER CELL;
CANCER CHEMOTHERAPY;
CANCER RECURRENCE;
CONFERENCE PAPER;
CYTOTOXIC T LYMPHOCYTE;
DONOR;
GRAFT VERSUS HOST REACTION;
GRAFT VERSUS LEUKEMIA EFFECT;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
KIDNEY CANCER;
LEUKEMIA;
MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION;
METASTASIS;
MOLECULAR CLONING;
RECIPIENT;
TISSUE SPECIFICITY;
CHEMISTRY;
CLINICAL TRIAL;
IMMUNOLOGY;
KIDNEY CARCINOMA;
KIDNEY TUMOR;
METABOLISM;
REVIEW;
T LYMPHOCYTE;
CARCINOMA, RENAL CELL;
CLINICAL TRIALS;
GRAFT VS HOST DISEASE;
GRAFT VS TUMOR EFFECT;
HUMANS;
KIDNEY NEOPLASMS;
LEUKEMIA;
MINOR HISTOCOMPATIBILITY ANTIGENS;
NEOPLASM METASTASIS;
T-LYMPHOCYTES;
|
EID: 18744402159
PISSN: 14653249
EISSN: None
Source Type: Journal
DOI: 10.1080/146532402320776116 Document Type: Conference Paper |
Times cited : (10)
|
References (3)
|